Molecule Holdings Inc.
Other OTCTotal Valuation
Molecule Holdings Inc. carries a market capitalization of 626,130.00, placing it among publicly traded companies globally. Its enterprise value stands at 6.36M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 626,130.00 |
| Enterprise Value | 6.36M |
Share Statistics
Molecule Holdings Inc. currently has 97.78M shares outstanding.
| Shares Outstanding | 97.78M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 0.38, and the price-to-book ratio stands at -0.10.
| PE Ratio | N/A |
| PS Ratio | 0.38 |
| PB Ratio | -0.10 |
| P/TBV Ratio | -0.12 |
| P/FCF Ratio | -6.83 |
| P/OCF Ratio | -6.83 |
Enterprise Valuation
| EV / Sales | 3.58 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 9.26 |
Financial Position
Molecule Holdings Inc. maintains a current ratio of 0.12, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -103.62, indicating conservative leverage, while an interest coverage ratio of -2.50 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.12 |
| Quick Ratio | 0.06 |
| Debt / Equity | -103.62 |
| Debt / EBITDA | -2.97 |
| Interest Coverage | -2.50 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -92.41 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.30 |
Income Statement
Over the trailing twelve months, Molecule Holdings Inc. generated 1.78M in revenue and converted that into -3.57M in net income, yielding earnings per share of -0.04. EBITDA reached -1.96M, while operating income came in at -2.62M.
| Revenue | 1.78M |
| Gross Profit | -449,696.00 |
| Operating Income | -2.62M |
| Pretax Income | -3.57M |
| Net Income | -3.57M |
| EBITDA | -1.96M |
| EBIT | -2.62M |
| Earnings Per Share (EPS) | -0.04 |
Balance Sheet
Molecule Holdings Inc. holds 141,927.00 in cash and equivalents against 5.83M in total debt, resulting in a net debt position of 5.62M. Total book value stands at -6.46M, with working capital of -7.71M providing operational flexibility.
| Cash & Cash Equivalents | 141,927.00 |
| Total Debt | 5.83M |
| Net Debt | 5.62M |
| Equity (Book Value) | -6.46M |
| Book Value Per Share | -0.07 |
| Working Capital | -7.71M |
Cash Flow
Molecule Holdings Inc. produced -98,668.00 in operating cash flow over the past twelve months. After subtracting -1.00 in capital expenditures, free cash flow totaled -98,669.00 - equivalent to 0.00 per share.
| Operating Cash Flow | -98,668.00 |
| Capital Expenditures | -1.00 |
| Free Cash Flow | -98,669.00 |
| FCF Per Share | 0.00 |
Margins
Molecule Holdings Inc. operates with a gross margin of -25.27, reflecting its pricing power and cost economics. The operating margin of -147.08 and net profit margin of -200.50 provide insight into operational efficiency.
| Gross Margin | -25.27 |
| Operating Margin | -147.08 |
| Pretax Margin | -200.50 |
| Profit Margin | -200.50 |
| EBITDA Margin | -110.23 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 12.46 |
| FCF Yield | -14.65 |
Stock Splits
Molecule Holdings Inc.'s most recent stock split took place on October 14, 2020 with a 10:1 split ratio.
| Last Split Date | 10/14/2020 |
| Split Ratio | 10:1 |
Scores
Molecule Holdings Inc. posts an Altman Z-Score of -11.80, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -11.80 |